Amorepacific Group Reports Strong Q1 2026 Results Amid Global Expansion

Amorepacific Group announced on the 10th that it achieved consolidated revenues of 1.2227 trillion won and operating profits of 137.8 billion won for Q1 2026, reflecting a 5.0% and 6.9% increase, respectively. This surge can be attributed to robust performance from its leading dermatological brands, including AESTURA and COSRX, along with an expanded Amazon business in North America and impressive growth in Japan with brands like Laneige and Hera.

During Q1, Amorepacific's sales increased by 6.4% year-on-year, with operating profits up by 7.6%, driving overall improvement across the group's performance. Notably, the domestic leader in dermatology, AESTURA, saw sales triple compared to the same period last year, bolstered by its A-Cica Line performance in North America and entry into 17 new European markets.

The global dermatological skincare brand COSRX transitioned to sales growth driven by the expansion of its RX Line and PDRN Line in North America, alongside successful promotions on Amazon. This signals a potential shift in brand perception as consumers increasingly opt for efficacy-driven products, enhancing repeat-purchase potential across key markets including EMEA and Japan.

Meanwhile, the premium skincare brand Laneige has fortified its global market presence, with standout products like the Neo Cushion and Juice Pop Box Lip Tint achieving strong performance in Japan, APAC, and South Korea. This positions Laneige strategically in a space where innovative product offerings can differentiate the brand amidst a saturated marketplace.

Domestically, Amorepacific reported a 9% increase in sales and a 65% increase in operating profit, attributed to solid sales growth across major brands and channels. The surge in profitability reflects an effective operational strategy that capitalizes on seasonal demand, with Sulwhasoo excelling in the luxury gift market and Hera gaining traction in online sales.

Internationally, despite a 6% increase in sales, operating profit fell by 18%, attributed to significant marketing investments aimed at expanding brand visibility. The performance of COSRX and AESTURA in North America exemplifies the effectiveness of the diversified product portfolio, which is pivotal for competitive differentiation in a growing segment.

Amorepacific’s medium- to long-term vision, 'Create New Beauty,' underscores its commitment to leading the global beauty and wellness sector. This vision encompasses five strategic initiatives: focusing on core global markets, enhancing integrated beauty solutions, developing bio-based anti-aging technologies, fostering organizational agility, and prioritizing AI-driven transitions in operations. Such strategies are likely to refine the operational framework and enhance customer engagement models, ensuring sustainability in a rapidly evolving industry landscape.